受强制性开放获取政策约束的文章 - Oleh Taratula了解详情
无法在其他位置公开访问的文章：3 篇
Surface-modified and internally cationic polyamidoamine dendrimers for efficient siRNA delivery
ML Patil, M Zhang, S Betigeri, O Taratula, H He, T Minko
Bioconjugate chemistry 19 (7), 1396-1403, 2008
强制性开放获取政策： US National Institutes of Health
Innovative strategy for treatment of lung cancer: targeted nanotechnology-based inhalation co-delivery of anticancer drugs and siRNA
O Taratula, OB Garbuzenko, AM Chen, T Minko
Journal of drug targeting 19 (10), 900-914, 2011
强制性开放获取政策： US National Institutes of Health
LHRH-targeted nanoparticles for cancer therapeutics
T Minko, ML Patil, M Zhang, JJ Khandare, M Saad, P Chandna, ...
Cancer Nanotechnology: Methods and Protocols, 281-294, 2010
强制性开放获取政策： US National Institutes of Health
可在其他位置公开访问的文章：50 篇
Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug resistant cancer cells
AM Chen, M Zhang, D Wei, D Stueber, O Taratula, T Minko, H He
Small (Weinheim an der Bergstrasse, Germany) 5 (23), 2673, 2009
强制性开放获取政策： US National Institutes of Health
Nanostructured lipid carriers as multifunctional nanomedicine platform for pulmonary co-delivery of anticancer drugs and siRNA
O Taratula, A Kuzmov, M Shah, OB Garbuzenko, T Minko
Journal of Controlled Release 171 (3), 349-357, 2013
强制性开放获取政策： US National Institutes of Health
Tumor targeted quantum dot-mucin 1 aptamer-doxorubicin conjugate for imaging and treatment of cancer
R Savla, O Taratula, O Garbuzenko, T Minko
Journal of controlled release 153 (1), 16-22, 2011
强制性开放获取政策： US National Institutes of Health
Surface-engineered targeted PPI dendrimer for efficient intracellular and intratumoral siRNA delivery
O Taratula, OB Garbuzenko, P Kirkpatrick, I Pandya, R Savla, ...
Journal of Controlled Release 140 (3), 284-293, 2009
强制性开放获取政策： US National Institutes of Health
Internally cationic polyamidoamine PAMAM-OH dendrimers for siRNA delivery: effect of the degree of quaternization and cancer targeting
ML Patil, M Zhang, O Taratula, OB Garbuzenko, H He, T Minko
Biomacromolecules 10 (2), 258-266, 2009
强制性开放获取政策： US National Institutes of Health
Nanocarrier-based systems for targeted and site specific therapeutic delivery
J Majumder, O Taratula, T Minko
Advanced drug delivery reviews 144, 57-77, 2019
强制性开放获取政策： US National Institutes of Health
Anti-HER2 IgY antibody-functionalized single-walled carbon nanotubes for detection and selective destruction of breast cancer cells
Y Xiao, X Gao, O Taratula, S Treado, A Urbas, RD Holbrook, RE Cavicchi, ...
BMC cancer 9, 1-11, 2009
强制性开放获取政策： US National Institutes of Health
Targeted nanomedicine for suppression of CD44 and simultaneous cell death induction in ovarian cancer: an optimal delivery of siRNA and anticancer drug
V Shah, O Taratula, OB Garbuzenko, OR Taratula, ...
Clinical Cancer Research 19 (22), 6193-6204, 2013
强制性开放获取政策： US National Institutes of Health
Biocompatible nanoclusters with high heating efficiency for systemically delivered magnetic hyperthermia
HA Albarqi, LH Wong, C Schumann, FY Sabei, T Korzun, X Li, ...
ACS nano 13 (6), 6383-6395, 2019
强制性开放获取政策： US National Institutes of Health
Multifunctional nanomedicine platform for cancer specific delivery of siRNA by superparamagnetic iron oxide nanoparticles-dendrimer complexes
O Taratula, O Garbuzenko, R Savla, Y Andrew Wang, H He, T Minko
Current drug delivery 8 (1), 59-69, 2011
强制性开放获取政策： US National Institutes of Health
Inhalation treatment of lung cancer: the influence of composition, size and shape of nanocarriers on their lung accumulation and retention
OB Garbuzenko, G Mainelis, O Taratula, T Minko
Cancer biology & medicine 11 (1), 44, 2014
强制性开放获取政策： US National Institutes of Health
Strategy to enhance lung cancer treatment by five essential elements: inhalation delivery, nanotechnology, tumor-receptor targeting, chemo-and gene therapy
OB Garbuzenko, A Kuzmov, O Taratula, SR Pine, T Minko
Theranostics 9 (26), 8362, 2019
强制性开放获取政策： US National Institutes of Health
Peptide-guided lipid nanoparticles deliver mRNA to the neural retina of rodents and nonhuman primates
M Herrera-Barrera, RC Ryals, M Gautam, A Jozic, M Landry, T Korzun, ...
Science advances 9 (2), eadd4623, 2023
强制性开放获取政策： US National Institutes of Health
Genotoxicity of different nanocarriers: possible modifications for the delivery of nucleic acids
V Shah, O Taratula, O B Garbuzenko, M L Patil, R Savla, M Zhang, ...
Current drug discovery technologies 10 (1), 8-15, 2013
强制性开放获取政策： US National Institutes of Health
Precision targeted therapy of ovarian cancer
J Sapiezynski, O Taratula, L Rodriguez-Rodriguez, T Minko
Journal of Controlled Release 243, 250-268, 2016
强制性开放获取政策： US National Institutes of Health
A tumor-activatable theranostic nanomedicine platform for NIR fluorescence-guided surgery and combinatorial phototherapy
X Li, C Schumann, HA Albarqi, CJ Lee, AWG Alani, S Bracha, ...
Theranostics 8 (3), 767, 2018
强制性开放获取政策： US National Institutes of Health
Exosomes from Osteosarcoma and normal osteoblast differ in proteomic cargo and immunomodulatory effects on T cells
RM Troyer, CE Ruby, CP Goodall, L Yang, CS Maier, HA Albarqi, ...
Experimental cell research 358 (2), 369-376, 2017
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定